$VKTX 3 SEC Filings

Filed On	Filing
07 Aug 2026	Form 3: Kelly-Gemmell Dorothy Elizabeth, Director No securities owned
03 Jun 2026	Form 3: Chen Hubert C, Chief Medical Officer No securities owned
26 Jan 2026	Form 3: Aubuchon Neil William, Chief Commercial Officer No securities owned
06 Jan 2021	Form 3: Zante Greg, Chief Financial Officer Holds 21,896 shares of Common Stock, par value $0.00001 per share
06 Jan 2021	Form 3: Mancini Marianna, Chief Operating Officer Holds 94,655 shares of Common Stock, par value $0.00001 per share
02 Jul 2019	Form 3: Rouan Sarah Kathryn, Director No securities owned
03 Jul 2018	Form 3: Masamune Hiroko, Chief Development Officer Holds 96,197 shares of Common Stock, par value $0.00001 per share
05 Jul 2017	Form 3: Rowland Charles A Jr, Director No securities owned
07 May 2015	Form 3: Ligand Pharmaceuticals Inc, 10% owner Holds 4,552,859 shares of Common Stock
28 Apr 2015	Form 3: Dinerman Michael, Chief Operating Officer Holds 1,575,000 shares of Common Stock, par value $0.00001 per share
28 Apr 2015	Form 3: Webster Stephen W, Director No securities owned
28 Apr 2015	Form 3: Morneau Michael, Chief Financial Officer No securities owned
28 Apr 2015	Form 3: Macartney Lawson, Director No securities owned
28 Apr 2015	Form 3: Lian Brian, Director Holds 3,650,000 shares of Common Stock, par value $0.00001 per share
28 Apr 2015	Form 3: Hanley Rochelle, Chief Medical Officer Holds 250,000 shares of Common Stock, par value $0.00001 per share
28 Apr 2015	Form 3: Foehr Matthew W, Director No securities owned
28 Apr 2015	Form 3: Singleton J Matthew, Director No securities owned

Comments